Intellectual Property

GC01 is protected by three patent families WO2005121172, WO2011073207 and WO2015197619 for which GlioCure has exclusive worldwide rights.

Depending on the targeted indication, GC01 is also eligible for orphan drug status, which confers market exclusivity for 7 to 10 years post marketing authorisation.


Patent WO2005121172

Download PDF

Patent WO2011073207

Download PDF

Patent WO2015197619

Download PDF